OGFR Activators are a distinct class of compounds that selectively enhance the functional activity of the Opioid Growth Factor Receptor (OGFR). These activators work through a myriad of signaling pathways to upregulate the receptor's activity, which plays a pivotal role in regulating cell proliferation and tissue organization. At the molecular level, these activators can influence the receptor conformation to promote its interaction with the native ligand, Opioid Growth Factor (OGF), also known as [Met^5]-enkephalin. This interaction typically inhibits cell division, suggesting that activators of OGFR may work by fine-tuning this response, rather than directly stimulating cell proliferation. Some activators may bind to allosteric sites on the receptor, thereby inducing a conformational change that increases the binding affinity or efficacy for the endogenous ligand. This mechanism ensures a sustained activation of OGFR without altering the levels of OGF itself. Additionally, certain small molecule activators might enhance the receptor's signaling by increasing its dimerization, a necessary step for effective signal transduction. This process can lead to the activation of downstream pathways that modulate cellular homeostasis and maintain tissue architecture.
Furthermore, OGFR Activators could also involve modulation of intracellular pathways that indirectly upregulate receptor function. For instance, by influencing the endocytic recycling of OGFR, these activators may maintain a steady-state receptor population on the cell surface, ready for OGF binding. This would potentiate the receptor's physiological signaling without affecting the ligand concentration. Some activators may even function by inhibiting phosphatases that typically dephosphorylate the receptor, thereby extending the duration of OGFR signaling once it has been activated by its ligand. It is also conceivable that certain activators enhance the expression of co-factors required for OGFR signaling, thus amplifying the pathway's response to OGF. By targeting these diverse, yet interconnected biochemical routes, OGFR Activators ensure the enhancement of OGFR's natural regulatory role in cellular processes. Each activator's mode of action is distinct, yet all converge on the common goal of enhancing OGFR signaling efficacy, thereby ensuring precision in controlling the biological outcomes modulated by this receptor.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate specific substrates potentially enhancing the functional activity of the OGFR by promoting cellular responses linked to OGFR signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate acts on its G protein-coupled receptors, initiating an intracellular signaling cascade that can lead to the activation of the PI3K/AKT pathway, which in turn may enhance OGFR activity through cross-talk mechanisms. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore which raises intracellular calcium levels, activating calcium-dependent signaling pathways. These pathways can upregulate the activity of OGFR by promoting cellular processes that are calcium-dependent and OGFR-mediated. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that reduces signaling through the AKT pathway. The inhibition of this pathway can lead to a compensatory response enhancing OGFR activity as the cell seeks to maintain homeostasis. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a PKC activator that modulates numerous signaling pathways, including those that can lead to the activation of OGFR by indirect mechanisms such as changes in cellular adhesion and migration associated with OGFR function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a polyphenol that acts as an antioxidant and has been shown to influence multiple signaling pathways, including those involving kinases that may enhance OGFR activity by modulating kinase-driven signaling networks. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore, similar to ionomycin, and it also raises intracellular calcium levels. These elevated calcium levels can activate signaling pathways that indirectly enhance OGFR activity by promoting calcium-dependent cellular responses. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. By inhibiting certain kinases, it may lead to selective activation of pathways involving OGFR by alleviating inhibition on signaling processes where OGFR is a component. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an inhibitor of MEK, which specifically inhibits the activation of MAPK/ERK. By dampening this pathway, there may be an indirect enhancement of OGFR activity due to the interconnectedness of cellular signaling networks. | ||||||